Ditchcarbon
  • Customers
  1. Organizations
  2. Nuo Therapeutics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 days ago

Nuo Therapeutics, Inc.

Company website

Nuo Therapeutics, Inc., a pioneering company in the regenerative medicine sector, is headquartered in the United States. Founded in 2010, Nuo Therapeutics focuses on developing innovative therapies for chronic wounds and other tissue-related conditions, leveraging its expertise in cell-based technologies. The company’s flagship product, Aurix™, is a unique autologous cell therapy that harnesses the body’s own healing capabilities, setting it apart in the competitive landscape of wound care solutions. Nuo Therapeutics has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. With a commitment to advancing patient care, Nuo Therapeutics continues to solidify its position as a leader in the regenerative medicine industry, dedicated to improving outcomes for patients worldwide.

DitchCarbon Score

How does Nuo Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Nuo Therapeutics, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

32%

Let us know if this data was useful to you

Nuo Therapeutics, Inc.'s reported carbon emissions

Nuo Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any specific reduction targets or initiatives related to climate commitments. As of now, Nuo Therapeutics has not cascaded any emissions data from a parent or related organisation, indicating that their climate strategy is still in the early stages or not publicly disclosed. Without specific emissions data or reduction initiatives, it is unclear how the company plans to address its carbon footprint or contribute to broader climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Nuo Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Nuo Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Nuo Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

XCell-Center

DE
Updated 16 days ago

Mesoblast Limited

AU
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Hollister Incorporated

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Convatec Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Acelity L.P. Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Molnlycke

SE
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250918.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy